Showing 1 - 9 of 9
The randomised controlled trial (RCT) has developed a central role in applied cost-effectiveness studies in health care as the vehicle for analysis. This paper considers the role of trial-based economic evaluation in this era of explicit decision making. It is argued that any framework for...
Persistent link: https://www.econbiz.de/10005689830
Persistent link: https://www.econbiz.de/10012406849
Persistent link: https://www.econbiz.de/10012082353
This explores the applicability of Sen's capability approach to the economic evaluation of health care programmes. An individual's 'capability set' describes his freedom to choose valuable activities and states of being ('functionings'). Direct estimation and valuation of capability sets is not...
Persistent link: https://www.econbiz.de/10005689904
No Abstract
Persistent link: https://www.econbiz.de/10005440546
Persistent link: https://www.econbiz.de/10005442630
No Abstract
Persistent link: https://www.econbiz.de/10005694134
No Abstract
Persistent link: https://www.econbiz.de/10005792783
The assumption of risk neutrality over discounted life years underlies the standard QALY model of individual preferences over health outcomes, and is thus implicitly assumed by NICE and other health technology advisory bodies worldwide. The primary objective of this article is to report a study...
Persistent link: https://www.econbiz.de/10008459083